Company page

Dbv Technologies Sa

Dbv Technologies Sa is a public company listed on the French market under the ticker DBV, with a market capitalization of approximately €799.37 million. The company focuses on developing innovative treatments for food allergies and other immunological diseases. Its commitment to advancing healthcare solutions positions it as a key player in the biotechnology sector.